Trending Articles

Five Things Pharmacists Should Know About Ventilator Associated Pneumonia (VAP)

IDStewardship

In this article a pharmacist with advanced training and experience in infectious diseases discusses five things pharmacists should know about ventilator associated pneumonia (VAP). Authored By: Lucia Rose, PharmD, BCIDP. Article Posted 1 December 2022.

Vitamin D Supplements Ineffective Treating Statin-associated Muscle Pain

Pharmacy Times

Muscle pain is a significant reason why many patients fail to remain adherent to their statin medication regimen.

103
103
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

Machine Learning Helps Predict Which Patients Respond to Immunotherapy

Pharmacy Times

DeepTCR system showed efficacy as a predictive clinical tool and provided information on the biological mechanisms that underlie how patients respond to immunotherapy.

132
132

Non-toxic and addiction free: The promise of a new pain med

PharmaVoice

Why South Rampart Pharma’s novel new molecule could be a key to solving the global pain epidemic

91

Industry Voices—The changing digital health landscape

Fierce Healthcare

Industry Voices—The changing digital health landscape. hlandi. Fri, 12/02/2022 - 11:20

101
101

Pfizer, BioNTech submit to FDA for Covid vaccine in under 5s

Pharma Phorum

FDA 79

What Does It Mean To Precept Responsibly & What Is The Precept Responsibly Podcast?

IDStewardship

**ARTICLE UNDER CONSTRUCTION**. In this article an experienced pharmacist discusses the concept of precepting responsibility and the new Precept Responsibly Podcast. pic pending. Authored by: Spencer Sutton, Pharm.D., ??other?? other?? Article Posted XX December 2022.

More Trending

UnitedHealth Group expects to bring in nearly $360B in revenue for 2023

Fierce Healthcare

UnitedHealth Group expects to bring in nearly $360B in revenue for 2023. hlandi. Wed, 11/30/2022 - 00:11

105
105

With buyout on Horizon, Amgen and Sanofi eye cash plays for rare disease drug maker

Fierce Pharma

With buyout on Horizon, Amgen and Sanofi eye cash plays for rare disease drug maker. fkansteiner. Fri, 12/02/2022 - 09:51

94

Sanofi and Queensland collaborate to build $190m research facility

Pharmaceutical Technology

Sanofi has signed an agreement with the Queensland Government in Australia to establish a $190m (A$280m) research facility in Brisbane. With the establishment of this Translational Science Hub, Queensland is set to become an international messenger ribonucleic acid (mRNA) vaccine hub.

Anticipated Developments on the Horizon for Patients With HR+/HER2- Breast Cancer

Pharmacy Times

Expert panelists discuss potential coming developments in the treatment landscape for breast cancer.

121
121

Healthcare tech’s biggest busts

PharmaVoice

The metaverse, blockchain, DCTs and more — here are some of the most recent fails in healthcare tech

76

Nkarta data supports natural killer cells in cancer treatment

Pharmafile

San Francisco, US-based Nkarta have been assessing the power of natural killer (NK) cells in oncology treatments. The treatment is as-yet unproven but appears hopefully at this early stage.

52

Mental health providers decry 'mind-numbing' prior authorization burdens as Senate debates reforms

Fierce Healthcare

Mental health providers decry 'mind-numbing' prior authorization burdens as Senate debates reforms. rking. Wed, 11/30/2022 - 13:13

94

Cannabinoids receptors: popular preclinical target but banned in 137 countries

Pharmaceutical Technology

Cannabinoid receptors are a popular therapeutic target for cannabinoid-based drugs in the treatment of pain, neurological disorders and inflammation, according to GlobalData’s Pharma Intelligence Centre Drugs database.

Substance Use Linked With Antiretroviral Therapy Non-adherence Among People With HIV

Pharmacy Times

Due to the correlation between virologic suppression and antiretroviral therapy adherence, understanding the impediments of adherence is of the utmost importance.

102
102

Evommune’s unique method of drug discovery is more than skin deep

PharmaVoice

The biotech is using human skin squares from plastic surgery to find the best immunological molecules for solving conditions like dermatitis

71

Positive results for BioVie’s Parkinson’s and Alzheimer’s phase 2 trials

Pharmafile

BioVie has announced positive results from two phase 2 trials which have been assessing NE3107’s efficacy in treating Parkinson’s Disease (PD) and Alzheimer’s Disease (AD).

52

AstraZeneca partner FibroGen slaps former employees with trade secret theft lawsuit

Fierce Pharma

AstraZeneca partner FibroGen slaps former employees with trade secret theft lawsuit. zbecker. Mon, 12/05/2022 - 10:31

79

Rough investments, rising costs push Cleveland Clinic's 9-month losses past $1.5B

Fierce Healthcare

Rough investments, rising costs push Cleveland Clinic's 9-month losses past $1.5B. dmuoio. Thu, 12/01/2022 - 15:00

91

Clinical Overview: Teplizumab for Type 1 Diabetes Mellitus

Pharmacy Times

Teplizumab is a humanized IgG1? Fc-nonbinding anti-CD3 monoclonal antibody that blocks T cells, preventing them from attacking beta cells.

102
102

Chasing a ‘holy grail’ cancer gene

PharmaVoice

Omega Therapeutics’ president and CEO Mahesh Karande on its attempts to drug the elusive c-Myc gene

52

Addressing leadership barriers for women in tech and pharma

Pharma Phorum

Contrary to Big Tech, historically the pharmaceutical industry has had a good reputation for being a female-positive industry. However, both industries share a common problem: failure to provide women with C-suite opportunities.

82

With FDA nod for its fecal microbiome therapy, Ferring becomes No. 1 in No. 2

Fierce Pharma

With FDA nod for its fecal microbiome therapy, Ferring becomes No. 1 in No. kdunleavy. Thu, 12/01/2022 - 10:14

FDA 91

KFF: For-profit hospital system margins surge past pre-pandemic levels

Fierce Healthcare

KFF: For-profit hospital system margins surge past pre-pandemic levels. rking. Mon, 12/05/2022 - 16:05

Pharmacists Play Essential Role in Addressing Health Care Disparities

Pharmacy Times

Diversity, equity, and inclusion programs in pharmacy can lead to better health outcomes for patients.

114
114

A historic approval could transform CSL from being ‘the biggest company no one has ever heard of’

PharmaVoice

The company’s head of R&D on its profile-raising FDA approval of a gene therapy that’s now the world’s most expensive drug

FDA 52

NHS expedites rollout of Bayer’s darolutamide for prostate cancer

Pharmaceutical Technology

The National Health Service (NHS) in England, UK, has expedited the rollout of Bayer ’s new life-extending drug, darolutamide, to treat the most advanced kinds of prostate cancer that have spread to other body parts.

PureTech readies oral CBD capsule for clinic to challenge Jazz’s Epidiolex

Fierce Pharma

PureTech readies oral CBD capsule for clinic to challenge Jazz’s Epidiolex. ntaylor. Thu, 12/01/2022 - 11:05

90

Digital health VCs eye healthcare workforce, cancer care as ripe for startups in 2023

Fierce Healthcare

Digital health VCs eye healthcare workforce, cancer care as ripe for startups in 2023. hlandi. Fri, 12/02/2022 - 06:26

87

FDA Approves Tenofovir Alafenamide for Adolescents With Chronic Hepatitis B Virus

Pharmacy Times

Tenofovir alafenamide (Vemlidy; Gilead Science) approved for the treatment of chronic hepatitis B virus infection in pediatric patients aged 12 years and older with compensated liver disease.

FDA 100

Big passion for small biotech and its potential to address complex diseases

PharmaVoice

A conversation with Teresa Nunes, chief medical officer of Allucent

53

Pfizer/BioNTech strike back in Moderna COVID vaccine lawsuit

Pharma Phorum

Pfizer and partner BioNTech have launched a countersuit against Moderna in a patent despite centring on their mRNA-based vaccines for COVID-19.

In free fall, Clovis defaults on loan and agrees to further restrict Rubraca use

Fierce Pharma

In free fall, Clovis defaults on loan and agrees to further restrict Rubraca use. kdunleavy. Mon, 12/05/2022 - 09:34

78

CDC awards $3.2B to public health departments

Fierce Healthcare

CDC awards $3.2B to public health departments. fdiamond. Fri, 12/02/2022 - 08:25

87

Trajectory of HR+/HER2- Breast Cancer Treatment

Pharmacy Times

Drs McHayleh and Vinokurov share final thoughts, highlighting the future of treatment for HR+/HER2- breast cancer.

118
118

AI company zeros in on compounds to treat addiction by rewiring the brain

PharmaVoice

GATC Health is driving a novel approach it believes could work for several major neurological conditions